Weekly Quick Hits (Research Triangle Park) – Week of May 29, 2023 By Alex KeownJune 2, 2023 Funding, Awards and Collaborations Clinical ink and Teckro Partner to Enhance Site User [….]
Weekly Quick Hits (Research Triangle Park) – Week of May 15, 2023
Published on :Weekly Quick Hits (Research Triangle Park) – Week of May 15, 2023 By Alex KeownMay 19, 2023 Funding, Awards and Collaborations Science 37 Wins MedTech Breakthrough Award for “Best Overall [….]
Labcorp Moves Forward With Planned CRO Spinout of Fortrea
Published on :Labcorp Moves Forward With Planned CRO Spinout of Fortrea By Alex KeownApril 25, 2023 North Carolina-based Labcorp is moving closer to the planned spinout of its independent clinical development business, [….]
BD, Labcorp Collaborate to Develop Flow Cytometry-Based Companion Diagnostics for Matching Patients with Treatments
Published on :BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration agreement with Labcorp (NYSE: LH), a leading global life sciences company, creating a framework to develop, manufacture, market and commercialize flow cytometry-based companion diagnostics (CDx) intended to match patients with life-changing treatments for cancer and other diseases.
4 Baltimore Companies Driving Cancer Screening Technologies
Published on :The cancer diagnostics market is surging, with an overall revenue growth expectation of hundreds of billions of dollars within the next eight years. The market is expected to grow to $257 billion by 2030, more than double the $124.9 billion valuation in 2021.